Logo do repositório
Tudo no RIUFPA
Documentos
Contato
Sobre
Ajuda
  • Português do Brasil
  • English
  • Español
  • Français
Entrar
Novo usuário? Clique aqui para cadastrar. Esqueceu sua senha?
  1. Início
  2. Pesquisar por Assunto

Navegando por Assunto "sarcopenia"

Filtrar resultados informando as primeiras letras
Agora exibindo 1 - 2 de 2
  • Resultados por página
  • Opções de Ordenação
  • Carregando...
    Imagem de Miniatura
    ItemAcesso aberto (Open Access)
    Efeito do exercício físico na força muscular, massa muscular e desempenho físico em pessoas sarcopenicas com câncer: uma revisão sistemática
    (Universidade Federal do Pará, 2024-12-20) GUEDES, Laerte Jonatas Leray; NEVES, Laura Maria Tomazi; http://lattes.cnpq.br/4235603520707156; https://orcid.org/0000-0002-3115-2571
    Cancer is the leading cause of secondary sarcopenia, representing a growing problem among people diagnosed with cancer. This condition is associated with unfavorable outcomes both in relation to disease progression and to the various types of cancer treatment. Physical exercise is recommended by several guidelines for cancer patients. However, the guidelines do not present specific recommendations for sarcopenia, and few systematic reviews have explored this topic. In addition, the effect of physical exercise on improving sarcopenia (muscle strength, muscle mass and physical performance) in cancer patients is not yet fully elucidated. Objective: To verify the effect of physical exercise on muscle strength, muscle mass and physical performance in sarcopenic people with cancer. Materials and methods: The study is a systematic review, we used the acronym PICOS as the inclusion criterion, population: adult patients diagnosed with cancer and diagnosed with sarcopenia; Intervention: physical exercise alone or associated with other interventions; control: patients in usual care, without treatment or without physical exercise; outcome: muscle strength, muscle mass, and physical performance; Types of studies: randomized controlled clinical trials. The databases used were Pubmed, Excerpta Medica database (EMBASE), Cochrane (CENTRAL), Physiotherapy Evidence Database (PEDro), Latin American and Caribbean Health Literature in Health Sciences (LILACS), Cumulative Index to Nursing and Allied Health Literature (CINAHL), and SPORTDiscus. For gray literature, Clinical trials.gov, Proquest, and the Catalog of Theses and Dissertations of the Coordination for the Improvement of Higher Education Personnel were checked, with no language or time limit. The searches were conducted until October 10, 2024. The risk of bias of the included studies was assessed by the Cochrane Risk of Bias Tool 2 and the level of evidence by the Grading of Recommendations Assessment, Development and Evaluation. Qualitative (narrative) synthesis was performed in the review, presenting the effect measures extracted from the studies individually. Results: Eight randomized controlled clinical trials were included. Three studies demonstrated an effect on skeletal muscle mass index in favor of resistance exercise (MD = 0.32 kg/m2, 95% CI [0.04; 0.60), resistance and aerobic exercise on appendicular skeletal muscle mass index (MD = 2.4 kg/m2, 95% CI [4.1; 1.30]) and resistance exercise associated with protein supplementation (MD = 0.03 kg/m2, 95% CI [0.1 0.5]). There were no differences between the intervention and control groups for the variables muscle strength and physical performance. The included studies presented risk of bias with some concerns and high risk. Additionally, all outcomes received a low level of evidence in GRADE. Conclusion: Although exercise appears to be safe and three articles indicate a possible effect on muscle mass, the studies did not have sarcopenia as a primary outcome, with prevalence rates of <50% of sarcopenic individuals in 7 studies. Thus, there is still a lack of evidence on the real effect of physical exercise on sarcopenia in cancer patients.
  • Carregando...
    Imagem de Miniatura
    ItemAcesso aberto (Open Access)
    Ratreio da sarcopenia em pessoas idosas acompanhadas no ambulatório do Hospital Universitário João de Barros Barreto
    (Universidade Federal do Pará, 2024-03-28) DIAS, Amanda Caroline Lobato; CARNEIRO, Saul Rassy; http://lattes.cnpq.br/9162153771863939; https://orcid.org/0000-0002-6825-0239
    Sarcopenia is an age-associated syndrome that has been associated with the risk of several adverse events, mainly functional decline and death. In the Brazilian health system, this constitutes a growing health problem, often with deficient identification, characterizing a challenge for the current health care model. It is therefore important to adopt preventive measures and to track the problem. Objective: To investigate sarcopenia and analyze screening instruments with variables of muscle function and functionality in elderly people followed at the geriatrics outpatient clinic of the Hospital Universitário João de Barros Barreto (HUJBB). Methodology: This is an observational, analytical, cross-sectional study with quantitative characteristics, carried out from January to October 2023 at HUJBB. Individuals of both sexes aged over 60 years, treated at the HUJBB geriatrics outpatient clinic, were included. Sarcopenia was assessed using the 2019 European Working Group on Sarcopenia in Older People- EWGSOP2 algorithm. A physical assessment was carried out consisting of the application of the Short Physical Performance Battery (SPPB) instrument, checking handgrip strength and Bioelectrical Impedance assessment (BIA). Results: 46 elderly people were evaluated, the majority of whom were female, 76.09%, with a prevalence of age between 69 and 79 (41.30%). Linear regression models were carried out taking sarcopenia screening instruments and their association with tests of physical performance, functionality and clinical aspects as the dependent variable. The best model for the SARC-CalF variable was obtained when adjustment was made for people with lung diseases (R2 = 0.97) with the association of the independent variables calf circumference, handgrip strength, gait speed and lean mass whose respective coefficients were: -0.49, 0.56, -0.173 and -0.179. For the dependent variable lean mass, the best adjustments were for hypertensive and cardiac patients (R2 = 0.82 and R2 = 0.87) with the independent variables calf circumference, handgrip strength, gait speed associated with the first model whose respective coefficients were (1.164, 0.52 and 0.29) and calf circumference (1.164) for heart disease patients. Conclusion: This research demonstrated that there is variation among sarcopenia screening instruments and that several factors must be considered when these tools are applied.
Logo do RepositórioLogo do Repositório
Nossas Redes:

DSpace software copyright © 2002-2025 LYRASIS

  • Configurações de Cookies
  • Política de Privacidade
  • Termos de Uso
  • Entre em Contato
Brasão UFPA